CXCL12 and neoplasm: Previous research indicated an involvement of the SDF-1/CXCL12–CXCR4 axis in tumorigenesis and metastatic progression by enhancing tumor cell migration towards the liver along a CXCL12 gradient, as well as by inhibiting tumor cell and CD8+ T-cell interaction in the TME [112,113].